Chronic Pain News and Research

RSS

UC San Diego researchers receive NIH grant to test efficacy of Sanofi's pain drug in treating Chagas disease

The National Center for Advancing Translational Sciences, part of the National Institutes of Health (NIH), has awarded James McKerrow, MD, PhD, director of the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, with a 2015 New Therapeutic Uses Award.

23 Jul 2015

Scott & White Healthcare - Round Rock now offers fully integrative medicine services to Central Texans

Scott & White Healthcare - Round Rock is now offering integrative medicine services to Central Texans that include massage therapy and acupuncture at two of its regional clinics: Scott & White Clinic - Avery Ranch and Baylor Scott & White Clinic - Round Rock South.

21 Jul 2015

New brain stimulation technique could improve physical performance

Researchers have discovered a new technique to enhance brain excitability that could improve physical performance in healthy individuals such as athletes and musicians.

17 Jul 2015

Psychosocial factors linked to pain in multiple sclerosis

Psychosocial factors are important and potentially modifiable determinants of persistent pain in patients with multiple sclerosis who are taking pain medication, research shows.

16 Jul 2015

Hyperbaric oxygen treatment effective for fibromyalgia

Fibromyalgia is almost impossible to diagnose. The chronic pain syndrome strikes an estimated 1 in 70 Americans, most of them women. The disorder is often triggered by head trauma, a neurological infection, or severe emotional stress, and is characterized by symptoms such as musculoskeletal pain, fatigue, memory loss and mood swings. Fibromyalgia is often mistaken for other culprits and most patients suffer months, even years, of unrelenting pain before being properly diagnosed. And once diagnosed, patients enjoy little respite because few therapies have been found to be effective in assuaging its symptoms.

15 Jul 2015

Cognitive behavioral therapy effective for insomnia with psychiatric and medical conditions

Cognitive behavioral therapy is a widely used nonpharmacologic treatment for insomnia disorders and an analysis of the medical literature by sleep researchers at Rush University Medical Center suggests it also can work for patients whose insomnia is coupled with psychiatric and medical conditions, according to an article published online by JAMA Internal Medicine.

14 Jul 2015

The Regency, Saddleback MemorialCare partner to open new Resident Wellness Center

The opening of The Regency's Resident Wellness Center serves as the official launch of their new partnership with Saddleback MemorialCare, an effort representing their shared interest in promoting happier, healthier aging.

12 Jul 2015

Internet-based program can help people manage their chronic pain, reduce reliance on opioids

Washington State University researchers have found that people can manage chronic pain and reduce their reliance on opioids through an Internet-based program that teaches non-medical alternatives like increased physical activity, thinking more positively and dealing with emotions.

8 Jul 2015

Evidence-based initiative aims to prevent avoidable hospital readmissions

A statewide effort led by key stakeholders in South Carolina successfully organized and implemented an evidence-based initiative aimed at improving the quality of healthcare transitions after hospital discharge to prevent avoidable readmissions.

8 Jul 2015

UC Davis scientists identify significant driver of neuropathic pain

Scientists at the University of California, Davis, have identified a key mechanism in neuropathic pain. The discovery could eventually benefit millions of patients with chronic pain from trauma, diabetes, shingles, multiple sclerosis or other conditions that cause nerve damage.

8 Jul 2015

Study demonstrates the important role of placebo effect in medical care

The "placebo effect" is often described as events that occur when patients show improvement from treatments that contain no active ingredients.

2 Jul 2015

1 in 4 people with histories of nicotine use, substance abuse likely to use opioid painkillers long-term

Opioid painkiller addiction and accidental overdoses have become far too common across the United States. To try to identify who is most at risk, Mayo Clinic researchers studied how many patients prescribed an opioid painkiller for the first time progressed to long-term prescriptions. The answer: 1 in 4. People with histories of tobacco use and substance abuse were likeliest to use opioid painkillers long-term.

2 Jul 2015

UTHealth researchers discover new light-activated proteins that work as 'off switches' for brain cells

Light switches for neurons have made enormous contributions to brain research by giving investigators access to "on switches" for brain cells. But, finding "off switches" has been much more challenging.

2 Jul 2015

New research reveals that male and female mice use different cells to process pain

New research released today in Nature Neuroscience reveals for the first time that pain is processed in male and female mice using different cells. These findings have far-reaching implications for our basic understanding of pain, how we develop the next generation of medications for chronic pain—which is by far the most prevalent human health condition—and the way we execute basic biomedical research using mice.

30 Jun 2015

Spinifex Pharmaceuticals enters into agreement to be acquired by Novartis

Spinifex Pharmaceuticals, Inc., a company focused on the development of new drugs for the treatment of chronic pain, today announces that it has agreed to the sale of Spinifex to Novartis International AG, for an upfront cash consideration of US$200 million plus undisclosed clinical development and regulatory milestone payments.

29 Jun 2015

Wockhardt obtains final approval from FDA for marketing 5mg/ 5ml of Oxycodone HCl liquid

Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 5mg/ 5ml of Oxycodone HCl liquid which is used in treatment of moderate to severe acute and chronic pain. Wockhardt is launching the product soon and will be amongst the few generic versions of this product in the market.

22 Jun 2015

ScinoPharm Taiwan, Raffles PharmaTech collaborate to manufacture Celecoxib

ScinoPharm Taiwan, Ltd. and Raffles PharmaTech announced today the collaboration to manufacture "Celecoxib," a non-steroidal and anti-inflammatory analgesic active pharmaceutical ingredient (API).

22 Jun 2015

Findings could lead to treatments for chronic pain caused by nerve damage

Non-narcotic treatments for chronic pain that work well in people, not just mice, are sorely needed. Drawing from human pain genetics, an international team led by Boston Children's Hospital demonstrates a way to break the cycle of pain hypersensitivity without the development of addiction, tolerance or side effects.

18 Jun 2015

AfBPM launches new educational tool to help assess, reduce medication abuse in home

The Alliance for Balanced Pain Management today launched a new educational tool – "Are You the Only One Taking Your Medicine?" – that consumers and health care providers can use to assess whether a home is at risk for medication misuse, abuse or diversion.

11 Jun 2015

INS announces winners of inaugural best abstract competition at 12th World Congress

The International Neuromodulation Society (INS) announced winners today of its inaugural best abstract competition at the 12th World Congress in Montreal.

10 Jun 2015

Chronic Pain News and Research

UC San Diego researchers receive NIH grant to test efficacy of Sanofi's pain drug in treating Chagas disease

Scott & White Healthcare - Round Rock now offers fully integrative medicine services to Central Texans

New brain stimulation technique could improve physical performance

Psychosocial factors linked to pain in multiple sclerosis

Hyperbaric oxygen treatment effective for fibromyalgia

Cognitive behavioral therapy effective for insomnia with psychiatric and medical conditions

The Regency, Saddleback MemorialCare partner to open new Resident Wellness Center

Internet-based program can help people manage their chronic pain, reduce reliance on opioids

Evidence-based initiative aims to prevent avoidable hospital readmissions

UC Davis scientists identify significant driver of neuropathic pain

Study demonstrates the important role of placebo effect in medical care

1 in 4 people with histories of nicotine use, substance abuse likely to use opioid painkillers long-term

UTHealth researchers discover new light-activated proteins that work as 'off switches' for brain cells

New research reveals that male and female mice use different cells to process pain

Spinifex Pharmaceuticals enters into agreement to be acquired by Novartis

Wockhardt obtains final approval from FDA for marketing 5mg/ 5ml of Oxycodone HCl liquid

ScinoPharm Taiwan, Raffles PharmaTech collaborate to manufacture Celecoxib

Findings could lead to treatments for chronic pain caused by nerve damage

AfBPM launches new educational tool to help assess, reduce medication abuse in home

INS announces winners of inaugural best abstract competition at 12th World Congress

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News